Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IP-10 | 14.0 | 78 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IP-10 | 13.0 | 96 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IP-10 | 12.5 | 86 | |
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | IP-10 | 11.0 | 87 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 1 | IP-10 | 16.0 | 77 | ||||
N2586 | EGF | 100 | ng/mL | 1 | IP-10 | 12.5 | 78 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | IP-10 | 12.0 | 85 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IP-10 | 11.0 | 60 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IP-10 | 12.0 | 48 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IP-10 | 13.0 | 74 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | IP-10 | 15.0 | 41 | |
N2586 | JNK-IN-11 | 0.3 | uM | 1 | IP-10 | 11.0 | 66 | ||||
RA2159 | IGF-I | 100 | ug/mL | 1 | IP-10 | 12.0 | 77 | ||||
RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | IP-10 | 13.0 | 67 | |
RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IP-10 | 12.0 | 59 | |
RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IP-10 | 13.0 | 88 | |
RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IP-10 | 11.0 | 93 | |
RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | IP-10 | 11.0 | 80 | |
RA2159 | 1 | IP-10 | 10.0 | 76 | |||||||
N2586 | IGF-I | 100 | ug/mL | 1 | IP-10 | 13.0 | 59 | ||||
N2586 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | IP-10 | 12.0 | 71 | |
N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IP-10 | 11.0 | 89 | |
N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IP-10 | 9.0 | 65 | |
N2586 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IP-10 | 13.0 | 54 | |
N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | IP-10 | 9.0 | 79 |